BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38182553)

  • 21. Inclined head position improves dose distribution during hippocampal-sparing whole brain radiotherapy using VMAT.
    Kim KS; Seo SJ; Lee J; Seok JY; Hong JW; Chung JB; Kim E; Choi N; Eom KY; Kim JS; Kim IA
    Strahlenther Onkol; 2016 Jul; 192(7):473-80. PubMed ID: 27221313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
    Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
    J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
    Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
    Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Directed, Scalp Sparing Intensity Modulated Whole Brain Radiotherapy for Brain Metastases.
    Kao J; Darakchiev B; Conboy L; Ogurek S; Sharma N; Ren X; Pettit J
    Technol Cancer Res Treat; 2015 Oct; 14(5):547-55. PubMed ID: 24750002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal-sparing whole-brain radiotherapy using Elekta equipment.
    Nevelsky A; Ieumwananonthachai N; Kaidar-Person O; Bar-Deroma R; Nasrallah H; Ben-Yosef R; Kuten A
    J Appl Clin Med Phys; 2013 May; 14(3):4205. PubMed ID: 23652251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.
    Popp I; Grosu AL; Fennell JT; Fischer M; Baltas D; Wiehle R
    Strahlenther Onkol; 2022 Jun; 198(6):537-546. PubMed ID: 35357511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.
    Cheah SK; Matthews T; Teh BS
    Asian Pac J Cancer Prev; 2016; 17(9):4233-4235. PubMed ID: 27797223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
    Kim Y; Kim SH; Lee JH; Kang DG
    Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.
    Popp I; Rau S; Hintz M; Schneider J; Bilger A; Fennell JT; Heiland DH; Rothe T; Egger K; Nieder C; Urbach H; Grosu AL
    Cancer; 2020 Jun; 126(11):2694-2703. PubMed ID: 32142171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole brain radiotherapy with hippocampal sparing using Varian HyperArc.
    Sprowls CJ; Shah AP; Kelly P; Burch DR; Mathews RS; Swanick CW; Meeks SL
    Med Dosim; 2021 Autumn; 46(3):264-268. PubMed ID: 33771435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study.
    Giaj Levra N; Sicignano G; Fiorentino A; Fersino S; Ricchetti F; Mazzola R; Naccarato S; Ruggieri R; Alongi F
    Radiol Med; 2016 Jan; 121(1):60-9. PubMed ID: 26231251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapy.
    Siglin J; Champ CE; Vakhnenko Y; Witek ME; Peng C; Zaorsky NG; Harrison AS; Shi W
    Pract Radiat Oncol; 2014; 4(6):378-83. PubMed ID: 25407858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
    Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
    BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the simulated half leaf width of a multileaf collimator on volumetric modulated arc therapy plan quality in hippocampal avoidance whole-brain radiotherapy.
    Li MH; Chen LJ; Chang CC; Tsai JT; Lin JC
    J Appl Clin Med Phys; 2022 May; 23(5):e13575. PubMed ID: 35239259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of multi-criteria optimization (MCO) for volumetric modulated arc therapy (VMAT) in hippocampal avoidance whole brain radiation therapy (HA-WBRT).
    Zieminski S; Khandekar M; Wang Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):184-190. PubMed ID: 29411526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-brain radiotherapy associated with structural changes resembling aging as determined by anatomic surface-based deep learning.
    Rammohan N; Ho A; Besson P; Kruser TJ; Bandt SK
    Neuro Oncol; 2023 Jul; 25(7):1323-1330. PubMed ID: 36734195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases.
    Rodrigues G; Yartsev S; Yaremko B; Perera F; Dar AR; Hammond A; Lock M; Yu E; Ash R; Caudrelier JM; Khuntia D; Bailey L; Bauman G
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1128-33. PubMed ID: 20675078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
    Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
    Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.